FreeStyle LibreLink App (with LibreView)

by Abbott  · Based in United States → — Real-time glucose readings, sent right to your patients' smartphones.
Endocrinology Family Medicine Internal Medicine
Website
Claim this tool
Is this the maker? Claim the company →

Free
Regulatory Status Disclosed

Overview

The FreeStyle LibreLink App, developed by Abbott, allows patients to monitor their glucose levels directly from a compatible smartphone using a FreeStyle Libre sensor. It provides real-time glucose readings, an 8-hour glucose history, and directional arrows indicating glucose trends. The app also generates in-app reports that visualize trends and patterns, helping patients understand their glucose control. When paired with LibreView, a secure, cloud-based diabetes management system, patients can automatically share their glucose data with healthcare professionals. This enables physicians to remotely review, analyze, and evaluate historical glucose data, facilitating informed treatment decisions and more productive patient conversations. LibreView offers customizable, intuitive reports, including a summary of glucose, sensor usage, carbohydrate, insulin, and quantitative hypoglycemic data over a 14-day period, as well as an Ambulatory Glucose Profile (AGP).

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Real-time glucose readings on smartphone
  • 8-hour glucose history
  • Glucose trend arrows
  • In-app reports for glucose patterns and trends
  • Automatic data upload to LibreView
  • Optional glucose alarms (with FreeStyle Libre 2 and 3 sensors)
  • Customizable reports for healthcare professionals
  • Remote patient monitoring
  • Time In Range graphs
  • Daily Patterns graphs

Use Cases

  • Continuous glucose monitoring for diabetes management
  • Remote monitoring of patient glucose data by healthcare professionals
  • Facilitating informed treatment decisions based on historical glucose data
  • Identifying glucose patterns and trends for therapy adjustments
  • Enhancing patient-provider communication regarding diabetes management
  • Supporting care coordination among healthcare teams

What Physicians Need to Know

Key Capabilities
The FreeStyle LibreLink app allows patients to monitor glucose levels from their smartphone by scanning a FreeStyle Libre sensor. It displays current glucose readings, trend arrows, and up to 8 hours of glucose history. Patients can add notes for food, insulin use, and exercise. The app generates various glucose reports, including the Ambulatory Glucose Profile (AGP), daily patterns, time in target range, low glucose events, average glucose, and an estimated HbA1c. It also offers customizable reminders and, with the FreeStyle Libre 2 system, real-time glucose alarms.
Clinical Utility
The FreeStyle LibreLink app, in conjunction with LibreView, provides healthcare professionals with access to consistent, clear, and intuitive glucose reports, enabling easier and faster identification of patterns and trends. This supports informed treatment decisions, optimization of treatment plans through remote patient monitoring, and better coordination of care among care team members. The reports can be customized, printed, or saved, and include summaries of glucose, sensor usage, carbohydrate, insulin, and hypoglycemic data.
Integration Options
The FreeStyle LibreLink app automatically uploads glucose data to LibreView, a secure cloud-based diabetes management system, when the phone has an internet connection. Healthcare professionals can access patient data through their LibreView account. Patients can also share their glucose data with up to 20 family and friends via the LibreLinkUp app. The FreeStyle Libre system and its digital health tools are integrated into platforms like Omada Health's digital coaching platform. The FreeStyle Libre 2 and 3 sensors are also authorized for use with various automated insulin delivery systems and smart insulin pens.
Compliance Status
The FreeStyle LibreLink app is FDA approved for compatible iPhones. LibreView is ISO27001/27018/27701 certified and HITRUST CSF Certified, and it meets or exceeds HIPAA requirements, complying with state and federal regulations for data security and privacy.
Pricing Model
The FreeStyle LibreLink app is free to download. LibreView is also free to set up and use for both patients and healthcare professionals.
User Experience
The app offers a convenient way to monitor glucose on the go with a painless one-second phone scan. It provides real-time glucose readings and allows for easy viewing of glucose history and trends. The reports in the app are noted to have more color, details, and interactivity compared to the FreeStyle Libre reader. However, some users have reported issues with data loss if the sensor expires before scanning, and occasional inaccuracies in readings. There have also been comments about the app's user-friendliness and the need for improved features like zooming in on graphs.
Support Quality
Abbott Diabetes Care provides customer support for the FreeStyle LibreLink app. Some users have reported unsatisfactory experiences with customer care regarding app issues and sensor malfunctions.
Implementation Complexity
Setting up the FreeStyle LibreLink app requires a compatible smartphone and registration with LibreView. Connecting to a healthcare professional's LibreView practice can be done by entering a Practice ID or accepting an email invitation. While the app itself is relatively straightforward, using both the app and a FreeStyle Libre reader with the same sensor requires starting the sensor with the reader first.
Evidence Base
The FreeStyle Libre and FreeStyle Libre 14 Day Flash Glucose Monitoring systems are continuous glucose monitoring (CGM) devices indicated for replacing blood glucose testing and detecting trends and patterns to aid in the detection of hyperglycemia and hypoglycemia, facilitating therapy adjustments in persons with diabetes. LibreView is intended to assist in the review, analysis, and evaluation of historical glucose data to support effective diabetes management.
Physician Tip

Encourage patients to consistently scan their FreeStyle Libre sensor with the LibreLink app and ensure internet connectivity for automatic data upload to LibreView. This provides a comprehensive glucose profile for more informed clinical decisions. Utilize the customizable reports in LibreView to identify glucose patterns, trends, and areas for intervention, such as time in range, daily patterns, and hypoglycemic events. Educate patients on the importance of fingerstick blood glucose tests when symptoms do not match sensor readings or when readings are suspected to be inaccurate. Leverage the remote monitoring capabilities of LibreView to track patient progress between visits and optimize treatment plans.

The FreeStyle LibreLink app seamlessly integrates with LibreView for secure, cloud-based data storage and sharing with healthcare professionals. It also connects with the LibreLinkUp app, allowing patients to share glucose data with family and friends. Additionally, the FreeStyle Libre system has integrations with various third-party digital health platforms and automated insulin delivery systems, expanding its utility in a connected care ecosystem.

Details

Category Endocrinology & Metabolic AI, Wearables & Remote Monitoring (RPM)
Pricing Free — The FreeStyle LibreLink app is free to download.
DeploymentCloud-based
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status 1 AI-estimated

The FreeStyle LibreLink app is FDA-approved for use with FreeStyle Libre and FreeStyle Libre 14-day sensors for individuals aged 18 and older with diabetes. The FreeStyle Libre 3 system, which integrates with the FreeStyle Libre 3 iOS and Android mobile apps, is cleared for use by individuals 4 years and older with diabetes.
Integrations
EHR Not specified
Specialties Endocrinology, Family Medicine, Internal Medicine

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate FreeStyle LibreLink App (with LibreView)

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

Abbott Newsroom
Abbott's FreeStyle Libre 3 System Receives FDA Clearance
Abbott announced that the U.S. Food and Drug Administration (FDA) has cleared its FreeStyle Libre 3 system, the smallest and most accurate 14-day continuous glucose monitoring (CGM) system, which integrates with the FreeStyle LibreLink app.
2022-05
Diabetes.co.uk
FreeStyle LibreLink app now compatible with Apple Watch
The FreeStyle LibreLink app has expanded its compatibility to include Apple Watch, allowing users to view their glucose readings directly on their smartwatch, enhancing convenience and accessibility for diabetes management.
2023-05
Journal of Diabetes Science and Technology
Real-world use of FreeStyle LibreLink app in people with type 1 and type 2 diabetes: a retrospective analysis
This peer-reviewed study analyzed real-world data from the FreeStyle LibreLink app, demonstrating its effectiveness in improving glucose monitoring frequency and time in range for individuals with both type 1 and type 2 diabetes.
2022-01
Abbott Newsroom
Abbott's FreeStyle Libre Portfolio Continues to Expand Global Reach and Reimbursement
Abbott highlighted the ongoing global expansion and increasing reimbursement coverage for its FreeStyle Libre portfolio, including the FreeStyle LibreLink app, making the technology more accessible to a wider patient population.
2023-02
MobiHealthNews
FDA Approves Abbott's FreeStyle Libre 2 iOS App for iPhone Users
The FDA granted approval for Abbott's FreeStyle Libre 2 iOS app, allowing iPhone users to receive real-time glucose readings and alerts directly on their smartphones, further integrating CGM data into daily life.
2021-07
Newswire.ca
FreeStyle LibreLink app now available for Android users in Canada
Abbott announced the availability of the FreeStyle LibreLink app for Android users in Canada, expanding access to the digital health solution for a broader segment of the population managing diabetes.
2021-03
Nutrients (MDPI)
Impact of the FreeStyle LibreLink App on Glycemic Control in Patients with Type 2 Diabetes: A Retrospective Study
This retrospective study investigated the impact of using the FreeStyle LibreLink app on glycemic control in type 2 diabetes patients, finding improvements in HbA1c levels and increased glucose monitoring frequency.
2022-08

Videos

Product demos, reviews, and walkthroughs for FreeStyle LibreLink App (with LibreView).

View all on YouTube

Frequently Asked Questions

The FreeStyle LibreLink app and LibreView utilize AI for pattern recognition in glucose data, identifying trends and potential hypoglycemic or hyperglycemic events. This helps physicians quickly assess patient adherence and make data-driven adjustments to treatment plans. The AI primarily focuses on data visualization and trend analysis rather than autonomous decision-making.
Abbott states that the FreeStyle LibreLink app and LibreView are designed with patient data privacy and security in mind, adhering to relevant healthcare regulations like HIPAA and GDPR. Data is encrypted both in transit and at rest, and access is restricted to authorized users. AI processing occurs within this secure environment, with anonymized or de-identified data used for broader trend analysis where appropriate.
The AI in the FreeStyle LibreLink app and LibreView is primarily a data analysis and visualization tool, not a diagnostic or prescriptive AI. It may not fully account for complex patient variables, such as acute illness, medication changes, or significant lifestyle shifts, which can influence glucose readings. Clinical judgment remains paramount, and the AI should be used as a supportive tool rather than a replacement for comprehensive medical evaluation.
Yes, several other CGM systems offer varying degrees of AI-powered insights, such as Dexcom G6 and G7, and Guardian Connect. These systems also provide trend analysis, predictive alerts, and integration with data platforms for physician review. The 'best' alternative often depends on specific patient needs, integration with existing EHRs, and the level of AI-driven insights desired by the physician.
The FreeStyle LibreLink app and LibreView are generally free for patients to download and use, as their primary function is to display data from the FreeStyle Libre sensors. The cost to patients primarily comes from the purchase of the disposable FreeStyle Libre sensors. For healthcare providers, access to LibreView for patient management is also typically free. There are no additional hidden costs specifically associated with the AI features, as they are integrated into the existing platform.
The FreeStyle LibreLink app and LibreView aim to improve patient compliance and engagement by providing real-time glucose data and easy-to-understand trends, empowering patients to better manage their diabetes. The AI contributes by highlighting patterns and potential issues, which can motivate patients to make timely adjustments to their diet or activity. The user-friendly interface and data sharing capabilities also encourage consistent use and communication with healthcare providers.

Related Tools

Virta Health
Virta Health
Endocrinology & Metabolic AI
Virta Health offers a virtual health program focused on reversing Type 2 diabetes, prediabetes, and obesity through a nutrition-first approach, continuous remote care, and personalized coaching.
Hybrid
PNOĒ
PNOĒ
Endocrinology & Metabolic AI
PNOĒ is a science-backed cardiometabolic analyzer that performs comprehensive breath-based assessments to measure 23 biomarkers, including VO₂ max, resting metabolic rate (RMR), fat burn efficiency, and biological age. It delivers a 360° snapshot of an individual's physiology by analyzing how oxygen flows through the lungs, heart, and cells. The insights generated are used to personalize nutrition, exercise, and longevity plans.
Varies
UpDoc Inc.
UpDoc Inc.
Clinical Decision Support & Reference
UpDoc is an FDA-cleared, enterprise-ready agentic clinical AI platform that integrates with EHRs to deploy AI agents for continuous, physician-governed care-related tasks, especially for chronic disease management.
Tiered subscription
GlucoSense
GlucoSense
Endocrinology & Metabolic AI
GlucoSense is an AI-powered CGM intelligence platform that provides personalized insights for individuals with diabetes and tools for population health management for healthcare providers and health plans. It integrates with various CGMs and wearables to offer real-time monitoring, AI-driven food logging, and simplified care team workflows.
Freemium
Endobits
Bio-Conscious Technologies Inc.
Clinical Decision Support & Reference
Endobits is an automated decision-support platform for diabetes and metabolic health that collects real-time data from various devices, EMRs, and EHRs to triage patients and prioritize those needing intervention.
$99 per patient per month for practices under 1,000 patients on service; volume pricing above that.
StackAI for Endocrinology Practices
StackAI
Documentation & Scribing
StackAI helps endocrinology practices deploy secure AI agents that automate patient support, summarize clinical context, and streamline document-driven workflows with enterprise governance and HIPAA-ready controls.
Freemium

See all Endocrinology & Metabolic AI tools →

More from Abbott

Abbott LibreView for Healthcare Professionals
Abbott
Endocrinology & Metabolic AI
Abbott LibreView for Healthcare Professionals is a secure, cloud-based diabetes management system that allows healthcare professionals to view, analyze, and share glucose data from Abbott FreeStyle Libre devices for informed treatment decisions and remote patient monitoring.
Free
Merlin.net
Abbott
Cardiology AI
Abbott's Merlin.net Patient Care Network (PCN) is a web-based remote monitoring platform for clinicians to manage data from patients with implanted cardiac devices, enabling remote follow-up, device performance monitoring, and informed clinical decisions.
Contact vendor for pricing

View company profile →

Suggest an Edit → | Last Verified: 2026-06-23 | First Added: 2026-06-23
AI Tool Finder
AI-powered search. Results may not be comprehensive.